Atai Beckley N.V (ATAI) 10-Year Financial Performance & Capital Metrics

ATAI • • Industrial / General

HealthcarePharmaceuticalsBiopharmaceutical R&DMental Health Therapeutics

AboutAtai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.Show more

Revenue $308K -1.9%
EBITDA -$102M +18.3%
Net Income -$149M -271.1%
EPS (Diluted) -0.93 -272.0%
Gross Margin 100%
EBITDA Margin -33187.66% +16.7%
Operating Margin -33341.23% +16.6%
Net Margin -48463.96% -278.3%
ROE -82.73% -424.5%
ROIC -45.02% +26.1%
Debt/Equity 0.21 +170.5%
Interest Coverage -32.87 +30.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 82 (top 18%)

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-75.27%

TTM811.78%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-19.9%

EPS CAGR

10Y-

5Y-

3Y-

TTM0%

ROCE

10Y Avg-58.83%

5Y Avg-64.69%

3Y Avg-45.97%

Latest-50.36%

Peer Comparison

Mental Health Therapeutics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CMPSCOMPASS Pathways plc	701.88M	7.31	-3.18			-6.31%		0.21
ATAIAtai Beckley N.V	1.35B	3.71	-3.99	-1.91%	-51.09%	-96.43%		0.21
NEUPNeuphoria Therapeutics Inc.	22.05M	4.10	-17.83		-40.76%	-30.24%	100%	0.01

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	20.38M	233K	314K	308K
Revenue Growth %	-	-	-	-0.99%	0.35%	-0.02%
Cost of Goods Sold+	6K	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-
Gross Profit+	-6K	0	20.38M	233K	314K	308K
Gross Margin %	-	-	1%	1%	1%	1%
Gross Profit Growth %	-	1%	-	-0.99%	0.35%	-0.02%
Operating Expenses+	17.84M	104.16M	156.18M	145.02M	125.78M	103M
OpEx % of Revenue	-	-	7.66%	622.4%	400.59%	334.41%
Selling, General & Admin	5.08M	80.73M	92.75M	70.35M	63.58M	47.54M
SG&A % of Revenue	-	-	4.55%	301.93%	202.49%	154.36%
Research & Development	12.76M	23.43M	47.96M	74.31M	62.2M	55.45M
R&D % of Revenue	-	-	2.35%	318.94%	198.1%	180.05%
Other Operating Expenses	0	0	15.48M	357K	0	0
Operating Income+	-17.85M	-104.16M	-135.81M	-144.79M	-125.47M	-102.69M
Operating Margin %	-	-	-6.66%	-621.4%	-399.59%	-333.41%
Operating Income Growth %	-	-4.84%	-0.3%	-0.07%	0.13%	0.18%
EBITDA+	-17.84M	-104.14M	-135.76M	-144.62M	-125.15M	-102.22M
EBITDA Margin %	-	-	-6.66%	-620.68%	-398.57%	-331.88%
EBITDA Growth %	-	-4.84%	-0.3%	-0.07%	0.13%	0.18%
D&A (Non-Cash Add-back)	6K	24K	47K	168K	319K	473K
EBIT	-17.47M	-92.14M	-120.33M	-134.26M	-36.63M	-145.28M
Net Interest Income+	23K	71K	205K	-375K	-809K	-2.35M
Interest Income	23K	71K	205K	548K	1.85M	778K
Interest Expense	0	0	0	923K	2.66M	3.12M
Other Income/Expense	-6.53M	-74.16M	-42.43M	-6.4M	82.59M	-47.71M
Pretax Income+	-24.38M	-178.32M	-178.23M	-151.19M	-42.88M	-150.41M
Pretax Margin %	-	-	-8.75%	-648.88%	-136.56%	-488.33%
Income Tax+	2K	305K	-3.99M	6.23M	1.02M	-356K
Effective Tax Rate %	0.58%	0.95%	0.94%	1.01%	0.94%	0.99%
Net Income+	-14.14M	-169.84M	-167.81M	-152.38M	-40.22M	-149.27M
Net Margin %	-	-	-8.24%	-654.01%	-128.1%	-484.64%
Net Income Growth %	-	-11.01%	0.01%	0.09%	0.74%	-2.71%
Net Income (Continuing)	-24.38M	-178.63M	-174.24M	-157.42M	-43.9M	-150.05M
Discontinued Operations	0	0	0	0	0	0
Minority Interest	1.03M	4.55M	9.05M	5.03M	1.35M	257K
EPS (Diluted)+	-0.11	-0.67	-0.83	-0.91	-0.25	-0.93
EPS Growth %	-	-5.09%	-0.24%	-0.1%	0.73%	-2.72%
EPS (Basic)	-0.11	-0.67	-0.83	-0.91	-0.25	-0.93
Diluted Shares Outstanding	152.57M	152.57M	160.68M	155.72M	158.83M	160.16M
Basic Shares Outstanding	152.57M	152.57M	160.68M	155.72M	158.83M	160.16M
Dividend Payout Ratio	-	-	-	-	-	-

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	39.15M	99.55M	375.08M	287.14M	185.59M	80.13M
Cash & Short-Term Investments	30.06M	97.25M	362.27M	273.11M	179.26M	62.33M
Cash Only	30.06M	97.25M	362.27M	190.61M	45.03M	17.5M
Short-Term Investments	0	0	0	82.5M	134.22M	44.83M
Accounts Receivable	8.7M	1.29M	6.32M	5.63M	2.26M	1.35M
Days Sales Outstanding	-	-	113.19	8.82K	2.62K	1.6K
Inventory	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-
Other Current Assets	207K	554K	756K	1.75M	846K	10.78M
Total Non-Current Assets+	22.97M	12M	39.08M	18.3M	107.89M	79.26M
Property, Plant & Equipment	21K	71K	149K	1.15M	2.2M	3.87M
Fixed Asset Turnover	-	-	136.75x	0.20x	0.14x	0.08x
Goodwill	0	0	0	0	0	331K
Intangible Assets	0	0	0	0	1.77M	3.25M
Long-Term Investments	22.95M	10.02M	27.76M	6.75M	91.66M	70.97M
Other Non-Current Assets	0	1.91M	11.18M	10.39M	12.25M	850K
Total Assets+	62.12M	111.55M	414.17M	305.44M	293.48M	159.39M
Asset Turnover	-	-	0.05x	0.00x	0.00x	0.00x
Asset Growth %	-	0.8%	2.71%	-0.26%	-0.04%	-0.46%
Total Current Liabilities+	1.61M	12.3M	20.93M	19.9M	20.12M	24.95M
Accounts Payable	0	0	6M	2.4M	4.59M	2.62M
Days Payables Outstanding	-	-	-	-	-	-
Short-Term Debt	0	0	0	0	0	9.36M
Deferred Revenue (Current)	0	0	0	0	0	0
Other Current Liabilities	1.48M	10.2M	265K	718K	1.1M	2.65M
Current Ratio	24.36x	8.09x	17.92x	14.43x	9.22x	3.21x
Quick Ratio	24.36x	8.09x	17.92x	14.43x	9.22x	3.21x
Cash Conversion Cycle	-	-	-	-	-	-
Total Non-Current Liabilities+	729K	3.88M	7.27M	19.78M	29.04M	17.88M
Long-Term Debt	157K	2.18M	743K	15.12M	17.88M	14.13M
Capital Lease Obligations	0	0	0	44K	990K	732K
Deferred Tax Liabilities	0	0	0	0	0	0
Other Non-Current Liabilities	572K	1.71M	6.53M	4.62M	10.18M	3.02M
Total Liabilities	2.34M	16.18M	28.21M	39.67M	49.16M	42.83M
Total Debt+	157K	2.18M	743K	15.34M	19.14M	24.71M
Net Debt	-29.91M	-95.07M	-361.52M	-175.27M	-25.89M	7.2M
Debt / Equity	0.00x	0.02x	0.00x	0.06x	0.08x	0.21x
Debt / EBITDA	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-
Interest Coverage	-	-	-	-156.87x	-47.24x	-32.87x
Total Equity+	59.78M	95.37M	385.96M	265.77M	244.32M	116.55M
Equity Growth %	-	0.6%	3.05%	-0.31%	-0.08%	-0.52%
Book Value per Share	0.39	0.63	2.40	1.71	1.54	0.73
Total Shareholders' Equity	58.75M	90.82M	376.91M	260.74M	242.96M	116.3M
Common Stock	6.57M	8.36M	18M	18.56M	18.57M	18.79M
Retained Earnings	-19.46M	-189.31M	-357.8M	-510.19M	-550.94M	-700.21M
Treasury Stock	0	0	0	0	0	0
Accumulated OCI	-1.43M	5.82M	-8.34M	-21.7M	-19.46M	-18.47M
Minority Interest	1.03M	4.55M	9.05M	5.03M	1.35M	257K

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-7.85M	-20.77M	-63.25M	-104.47M	-84.12M	-82.44M
Operating CF Margin %	-	-	-3.1%	-448.36%	-267.89%	-267.65%
Operating CF Growth %	-	-1.65%	-2.05%	-0.65%	0.19%	0.02%
Net Income	-24.38M	-178.63M	-174.24M	-157.42M	-43.9M	-150.05M
Depreciation & Amortization	6K	24K	47K	168K	319K	473K
Stock-Based Compensation	57K	67.16M	63.36M	42.38M	32.98M	25.49M
Deferred Taxes	7.54M	56.35M	39.13M	5.07M	0	0
Other Non-Cash Items	9.06M	29.88M	16.06M	8.67M	-80.99M	50.85M
Working Capital Changes	-126K	4.45M	-7.6M	-3.33M	7.47M	-9.2M
Change in Receivables	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0
Change in Payables	249K	1.7M	2.3M	-3.03M	2.14M	-1.87M
Cash from Investing+	-9.03M	-28.27M	-81.28M	-86.85M	-53.3M	59.17M
Capital Expenditures	-19K	-59K	-1.13M	-773K	-259K	-95K
CapEx % of Revenue	-	-	0.06%	3.32%	0.82%	0.31%
Acquisitions	-	-	-	-	-	-
Investments	-	-	-	-	-	-
Other Investing	-7.32M	-2.2M	-2.6M	-3.25M	-5.84M	-8.1M
Cash from Financing+	40.39M	113.05M	409.86M	20.79M	-8.36M	5.37M
Debt Issued (Net)	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-
Other Financing	-2.29M	-1.89M	2.42M	5.18M	-8.36M	-161K
Net Change in Cash	-	-	-	-	-	-
Free Cash Flow+	-7.87M	-20.82M	-64.37M	-105.49M	-84.71M	-82.53M
FCF Margin %	-	-	-3.16%	-452.75%	-269.77%	-267.96%
FCF Growth %	-	-1.65%	-2.09%	-0.64%	0.2%	0.03%
FCF per Share	-0.05	-0.14	-0.40	-0.68	-0.53	-0.52
FCF Conversion (FCF/Net Income)	0.55x	0.12x	0.38x	0.69x	2.09x	0.55x
Interest Paid	0	0	0	0	1.92M	2.16M
Taxes Paid	0	0	0	0	1.48M	411K

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-23.65%	-218.94%	-69.73%	-46.76%	-15.77%	-82.73%
Return on Invested Capital (ROIC)	-44.81%	-517.81%	-823.56%	-188.97%	-60.92%	-45.02%
Gross Margin	-	-	100%	100%	100%	100%
Net Margin	-	-	-823.56%	-65401.29%	-12810.19%	-48463.96%
Debt / Equity	0.00x	0.02x	0.00x	0.06x	0.08x	0.21x
Interest Coverage	-	-	-	-156.87x	-47.24x	-32.87x
FCF Conversion	0.55x	0.12x	0.38x	0.69x	2.09x	0.55x
Revenue Growth	-	-	-	-98.86%	34.76%	-1.91%

Revenue by Segment

	2021	2022	2023	2024
Research And Development Services	600K	200K	300K	300K
Research And Development Services Growth	-	-66.67%	50.00%	0.00%

Frequently Asked Questions

Growth & Financials

Atai Beckley N.V (ATAI) reported $3.0M in revenue for fiscal year 2024.

Atai Beckley N.V (ATAI) saw revenue decline by 1.9% over the past year.

Atai Beckley N.V (ATAI) reported a net loss of $154.2M for fiscal year 2024.

Dividend & Returns

Atai Beckley N.V (ATAI) has a return on equity (ROE) of -82.7%. Negative ROE indicates the company is unprofitable.

Atai Beckley N.V (ATAI) had negative free cash flow of $90.3M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener